Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | KDM5A | P29375 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL418559 | 0.95 | LCK (0.46) | LCKDNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL5667065 | 0.95 | LCK (0.46) | LCKDNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL12552468 | 0.92 | LCK (0.50) | LCKDNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL18912879 | 0.92 | LCK (0.44) | LCKDNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL7861470 | 0.92 | LCK (0.44) | LCKDNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL18785200 | 0.90 | DNM1 (0.48) | LCKDNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL13154393 | 0.90 | LCK (0.48) | LCKDNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL26713010 | 0.90 | DNM1 (0.46) | LCKDNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL3237514 | 0.90 | DNM1 (0.46) | LCKDNM1MEN1KMT2AALDH1A1 | |
| Bromide SCHEMBL10786110 | 0.90 | DNM1 (0.43) | LCKDNM1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0298096-A1 | METHOD FOR STABILIZING CLAYISH FORMATIONS | CECA S.A. (FR) | 1989-01-11 | — | — | EP | claimed |
| WO-1988004680-A1 | METHOD FOR STABILIZING CLAYISH FORMATIONS | CECA S.A. (FR) | 1988-06-30 | — | — | WO | claimed |
| EP-4406982-A2 | PRODUCTION OF ISOBUTYLENE HOMO- OR COPOLYMER DERIVATIVES | BASF SE (DE) | 2024-07-31 | — | — | EP | disclosed |
| US-11306161-B2 | Preparation of isobutene homo- or copolymer derivatives | BASF SE (DE) | 2022-04-19 | — | — | US | disclosed |
| EP-3170883-B1 | CLEANING PRODUCT | PROCTER & GAMBLE (US) | 2021-08-11 | — | — | EP | disclosed |
| US-20200325253-A1 | PREPARATION OF ISOBUTENE HOMO- OR COPOLYMER DERIVATIVES | BASF SE (DE) | 2020-10-15 | — | — | US | disclosed |
| US-10745496-B2 | Preparation of isobutene homo- or copolymer derivatives | BASF SE (DE) | 2020-08-18 | — | — | US | disclosed |
| EP-3348629-A1 | CLEANING PRODUCT | The Procter & Gamble Company (US) | 2018-07-18 | — | — | EP | disclosed |
| US-20170204075-A1 | AMINOALCOHOL LIPIDOIDS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2017-07-20 | — | — | US | disclosed |
| US-9688791-B2 | High-reactivity polyisobutylene having a high content of vinylidene double bonds in the side chains | BASF SE (DE) | 2017-06-27 | — | — | US | disclosed |
| EP-3019493-B1 | MODIFIED BET-PROTEIN INHIBITING DIHYDROCHINOXALINONES AND DIHYDROPYRIDOPYRAZINONES | Bayer Pharma AG (DE) | 2017-06-14 | — | — | EP | disclosed |
| EP-0385039-A1 | Synthesis of carbonyl compounds | BP Chimie Société Anonyme (FR) | 1990-09-05 | — | — | EP | disclosed |
| EP-0384086-A1 | Synthesis of hydrocarbyl amines | BP Chimie Société Anonyme (FR) | 1990-08-29 | — | — | EP | disclosed |
| WO-1990009371-A1 | SYNTHESIS OF HYDROCARBYL AMINES | BP CHEMICALS LIMITED (GB) | 1990-08-23 | — | — | WO | disclosed |
| EP-0298096-A1 | METHOD FOR STABILIZING CLAYISH FORMATIONS | CECA S.A. (FR) | 1989-01-11 | — | — | EP | disclosed |
| WO-1988004680-A1 | METHOD FOR STABILIZING CLAYISH FORMATIONS | CECA S.A. (FR) | 1988-06-30 | — | — | WO | disclosed |
| US-4169859-A | POLYMERIC KETONE FROM ALPHA-OLEFIN AND ACYL HALIDE CATALYST, ASHLESS DETERGENTS | ATLANTIC RICHFIELD COMPANY (US) | 1979-10-02 | — | — | US | disclosed |
| US-4157339-A | Phosphonamidic condensation reaction product | ATLANTIC RICHFIELD COMPANY (US) | 1979-06-05 | — | — | US | disclosed |
| US-4119552-A | DISPERSANT, AMIDATION OF PHENOXYALKANOIC ACID, REACTION OF THE AMIDE WITH A BORON COMPOUND | EDWIN COOPER AND COMPANY LIMITED (GB) | 1978-10-10 | — | — | US | disclosed |
| US-4028414-A | LUBE OIL DETERGENT | ATLANTIC RICHFIELD COMPANY (US) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170204075-A1 | AMINOALCOHOL LIPIDOIDS AND USES THEREOF | PHOSPHO1, PNMT, AASDHPPT | LCK 3165/4885DNM1 640/4885MEN1 2403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.